Senseonics Holdings, Inc.
NASDAQ:SENSMedical - Devices
-$0.09 today
- Market cap
- $533.56M
- Beta
- 0.97
- P/E (TTM)
- -3.5
- EPS (TTM)
- -$1.90
Volume 0.87M
Average 0.71M
SENS Other Financing Activities
Financing cash flows not reported separately.
Senseonics Holdings, Inc.NASDAQ: SENS
Other Financing Activities · Q1 FY2026 · quarter ended Mar 2026
Other financing activities turns negative
Q1 FY2026 other financing activities was -$150K, compared with $62K a year earlier. Trailing-twelve-month other financing activities was -$2.22M. Over 3 fiscal years it compounded at +13.1% a year.
Context
- Other financing activities amounted to 6.1% of revenue in FY2025, down 0.5 pp from a year earlier.
- Other financing activities increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly other financing activities holds near -$150K or moves back toward the trailing-twelve-month quarterly average of -$554K.
Sources:Cash FlowText generated from reported figures; not investment advice.
Other Financing Activities history
USD · from the cash flow
- Latest · FY2025
- (2.15M) USD
- Year-over-year change
- -44.7%
| Period | Period end | Other Financing Activities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (2.15M) | -44.7% |
| FY2024 | 2024-12-31 | (1.48M) | -112.6% |
| FY2023 | 2023-12-31 | 11.74M | +890.3% |
| FY2022 | 2022-12-31 | (1.49M) | -554.6% |
| FY2021 | 2021-12-31 | (227K) | — |
Other Financing Activities vs competitors
How SENS compares with its peers on the latest reported figures
- SENS's LTM Mar 2026 other financing activities of $2.22M is the 4th largest of the 6 companies compared; the peer median is $1.05M.
- Its year-over-year change of -80.7% is the 4th highest of 5, against a peer median of +86.7%.
- Other financing activities amounts to 5.4% of revenue for SENS, versus a peer median of 2.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $1.25B | +19781.0% | -26.0% | 25.2% | |
MMEDMiniMed Group, Inc. Common Stock | LTM Jul 2026 | $205M | — | -1.3% | 6.4% |
| LTM Jun 2026 | $83.1M | +62.3% | — | 2.7% | |
| LTM Mar 2026 | $2.22M | -80.7% | +13.1% | 5.4% | |
| LTM Mar 2026 | $1.05M | +111.1% | — | 0.1% | |
| LTM Mar 2026 | $0 | -100.0% | — | 0.0% | |
| Peer median (excluding SENS) | $1.05M | +86.7% | -13.7% | 2.7% | |
Competitors are the stored peer set for SENS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (302.47M) | 142.12M | (60.39M) | (78.62M) | (69.11M) |
| Depreciation & Amortization | 1.24M | 985K | 1.28M | 1.48M | 91K |
| Deferred Income Tax | 229.17M | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 9.03M | 8.62M | 8.67M | 9.23M | 10.15M |
| Change in Working Capital | (1.5M) | (2.47M) | (3.97M) | 865K | (3.28M) |
| Accounts Receivables | 1.01M | (478K) | (2.19M) | (2.7M) | (6.77M) |
| Inventory | (1.04M) | (989K) | (1.64M) | 696K | (2.98M) |
| Accounts Payables | (559K) | (785K) | 2.3M | (1.83M) | 1.22M |
| Other Working Capital | (922K) | (219K) | (2.43M) | 4.7M | 5.24M |
| Other Non-Cash Items | 8.46M | (215.56M) | (15.76M) | 6.59M | 3.02M |
| Operating Cash Flow | (56.08M) | (66.31M) | (70.16M) | (60.47M) | (59.13M) |
| Capital Expenditures | (210K) | (312K) | (350K) | (2.24M) | (1.12M) |
| Acquisitions (Net) | 210K | (27.19M) | 0 | 0 | 0 |
| Purchases of Investments | (154.51M) | (104.71M) | (68.54M) | (58.02M) | (100.69M) |
| Sales of Investments | 5.98M | 131.9M | 158.6M | 93.1M | 48.39M |
| Other Investing Activities | (210K) | 27.19M | 0 | 0 | 0 |
| Investing Cash Flow | (148.75M) | 26.88M | 89.71M | 32.84M | (53.42M) |
| Debt Repayment | (2.84M) | (2.93M) | 1.25M | 9.95M | (20.4M) |
| Common Stock Issued | 200.37M | 34.17M | 7.38M | 18.36M | 100.73M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (227K) | (1.49M) | 11.74M | (1.48M) | (2.15M) |
| Financing Cash Flow | 220.08M | 41.76M | 20.37M | 26.83M | 78.19M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 15.26M | 2.33M | 39.92M | (797K) | (34.36M) |
| Free Cash Flow | (56.29M) | (66.62M) | (70.51M) | (62.7M) | (60.25M) |
Senseonics Holdings, Inc.
NASDAQ:SENS
Intrinsic Alpha fair value
Locked
Current Price
$9.74
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.